相关实验视频
Updated: Sep 14, 2025

11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
94.8K
甲胺通过GIP增强肠道脂质传感,以抑制食
Rachel Kuah1,2, Melissa T Wang1,2, Zeyu Yang1
1Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Diabetes
|July 22, 2025
概括
高脂肪饮食会扰乱上小肠脂质感应,但甲福林通过增强依赖葡萄糖的胰岛素聚 (GIP) 信号传递到孤独管 (NTS) 的核,减少食物摄入来恢复这种途径.
科学领域:
- 胃肠道学和新陈代谢学
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
背景情况:
- 上小肠 (USI) 脂质感应通常会减少食物摄入量.
- 高脂肪 (HF) 食会损害USI脂质感应,阻碍食欲控制.
- 在高频条件下受损USI脂质感应背后的机制尚未完全理解.
研究的目的:
- 为了研究HF养对USI脂质传感的影响.
- 确定依赖葡萄糖的胰岛素型多 (GIP) 和其受体 (GIPR) 在食欲调节中的作用.
- 探索甲福明在恢复USI脂质感应和减少HF养大鼠的食方面的潜力.
主要方法:
- 在雄性大鼠中HF养.
- USI脂质输注和GIP分泌量的测量.
- 在特定的大脑区域 (NTS,中基底下丘脑,前脑区域) 输注GIP受体 (GIPR) 激素剂.
- 在NTS中GIPR的遗传淘汰.
- 梅特福林的管理.
主要成果:
- HF养损害了USI脂质感应,减少了GIP分泌和再养抑制.
- 甲胺恢复了HF养大鼠的USI脂质感应.
- 在NTS中激活GIPR,但不是其他大脑区域,减少了再养.
- 在高频率大鼠中,NTS GIPR激活的厌食效应被保留,并且取决于GIPR的存在.
- 抑制NTS GIPR阻断了甲福林对高压大鼠再食的影响.
结论:
- USI脂质感应受损于HF养.
- 甲胺通过增强内分泌GIP到NTS GIPR轴的作用恢复了HF大鼠的USI脂质感应.
- 准细肠脂质传感和GIP作用可能为肥胖症治疗提供策略.
相关概念视频
Glucagon-like Receptor Agonists
421
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
421
Dipeptidyl Peptidase 4 Inhibitors
262
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
262
Oral Hypoglycemic Agents: Biguanides and Glitazones
305
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
305
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
265
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
265
Oral Hypoglycemic Agents: Glinides
263
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
263
Regulation of Food Intake
481
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
481

